Impact of Assessment and Management of Comorbidities in Internal Medicine on Cardiovascular Risk

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 21, 2024

Primary Completion Date

May 21, 2027

Study Completion Date

November 21, 2027

Conditions
Adverse Cardiac EventMajor Adverse Cardiac Events
Interventions
OTHER

Screening and management of cormobidities

"During the routine care assessment and as part of the research, patients will :~* Fill in cardiovascular risk assessment score: Life's simple 7~* Provide an additional blood sample (1 dry tube of 7 mL and 1 heparin tube of 7 mL) during their biological testing. These samples will be used for lipoprotein (a) testing and biological collection.~After hospital discharge, patients will be contacted by telephone at 3 and 12 months for re-evaluation and will fill in the Life's simple 7 score. Prior to this contact, patients will have biological tests as prescribed just before hospital discharge (including blood ionogram, creatinine, liver assessment, lipid assessment (LDL, HDL, triglycerides), fasting blood sugar test, A1C test, urinary albumin/creatinine ratio, protein/ urinary creatinine ratio). They will weigh themselves and take blood pressure self-measurements over 3 days."

Trial Locations (1)

Unknown

RECRUITING

University Hospital, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER